The Ministry of Food and Drug Safety issued a disposition revoking the sales licenses of all hypertension drugs manufactured by Jeil Pharmaceutical after the company was found to have submitted fabricated data for approval. A total of 44 items from 15 companies including Jeil Pharmaceutical were issued the disposition.

The GMP investigation that has been initiated after Binex was found to have illegally manufactured products in March has been closing on and putting the pharmaceutical companies at risk.

With HLB Pharmaceutical’s ‘Twinstel tab.’ marking the start of MFDS’ dispositions, the authorities have revoked the license of 14 companies’ hypertension drugs by the 16th.

Lee, Tak-Sun(hooggasi2@dailypharm.com)